Address

OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States

Open map


Recent investment activity

KANDO id: 29979

Corporate information

Official name
OrbiMed Advisors Limited Liability Company
Registration country

Funding rounds

Investment preferences

Investment focus themes
Top investment portfolio themes

Actual initial investment stage
N/A (2)
Venture (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 114
Profile Country Date Funding
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series F
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series E Follow-on investment
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series D Follow-on investment
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series C Initial investment
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. Series B
Adiana Inc Series D
Adimab LLC Developer of a human antibody discovery platform in yeast. Series D
Adolor Corp N/A
Aerogen Medical device and drug delivery company N/A
Affimed Therapeutics AG Antibody therapeutics for cancer and inflammatory diseases. N/A
Agensys Inc Series D
Amarin Pharmaceuticals Inc N/A
Ambit Biosciences Inc A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer. Series D
Amnis Corp A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. Series D
Amnis Corp A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. Series C
Amnis Corp A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. Series B
Anthera Pharmaceuticals Inc N/A
Aragon Pharmaceuticals Inc Aragon Pharmaceuticals is a privately held, small-molecule drug discovery company. N/A
Arena Pharmaceuticals Inc N/A
arGEN-X BV Innovation-driven biopharmaceutical company. N/A
Armo BioSciences Inc Late-stage immuno-oncology company. Series C-1 Follow-on investment
Arsanis Biosciences GmbH N/A
Arteaus Therapeutics LLC A product-focused biotechnology company developing a novel treatment for migraine prevention. N/A
ARYx Therapeutics Inc N/A Initial investment
Athersys Inc Develops therapeutic products to treat significant and life-threatening diseases. N/A

Past employees

Selected Products / Customers

Financials